HINGE HEALTH INC-A (HNGE) Forecast, Price Target & Analyst Ratings

NYSE:HNGE • US4333131039

Current stock price

38 USD
-0.29 (-0.76%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HINGE HEALTH INC-A (HNGE).

Forecast Snapshot

Consensus Price Target

Price Target
$59.42
+ 56.36% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2026
EPS Estimate
$0.39
Revenue Estimate
175.12M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.61%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$59.42
Upside
+ 56.36%
From current price of $38.00 to mean target of $59.42, Based on 23 analyst forecasts
Low
$43.43
Median
$60.18
High
$75.60

Price Target Revisions

1 Month
0.54%
3 Months
-9.39%

Price Target Summary

23 Wall Street analysts provided a forecast for the next 12 months for HNGE. The average price target is 59.42 USD. This implies a price increase of 56.36% is expected in the next year compared to the current price of 38.
The average price target has been revised downward by 9.39% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HNGE Current Analyst RatingHNGE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

HNGE Historical Analyst RatingsHNGE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -9 -8 -7 -6 -5 -4 -3 -2 -1 0 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
82.61%
HNGE was analyzed by 23 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HNGE.
In the previous month the buy percentage consensus was at a similar level.
HNGE was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-08Evercore ISI GroupMaintains Outperform -> Outperform
2026-03-11RBC CapitalMaintains Outperform -> Outperform
2026-02-11CitizensReiterate Market Outperform -> Market Outperform
2026-02-11NeedhamReiterate Buy -> Buy
2026-02-11RBC CapitalMaintains Outperform -> Outperform
2026-02-11BarclaysMaintains Overweight -> Overweight
2026-02-11Evercore ISI GroupMaintains Outperform -> Outperform
2026-02-11Canaccord GenuityMaintains Buy -> Buy
2026-01-23Freedom Capital MarketsInitiate Buy
2026-01-09Wells FargoInitiate Overweight
2026-01-09Piper SandlerMaintains Overweight -> Overweight
2026-01-08KeybancMaintains Overweight -> Overweight
2026-01-06NeedhamReiterate Buy -> Buy
2026-01-05BarclaysMaintains Overweight -> Overweight
2025-11-05BarclaysMaintains Overweight -> Overweight
2025-11-05Canaccord GenuityMaintains Buy -> Buy
2025-11-05Piper SandlerReiterate Overweight -> Overweight
2025-10-08Evercore ISI GroupMaintains Outperform -> Outperform
2025-09-23Morgan StanleyMaintains Overweight -> Overweight
2025-09-11StifelMaintains Buy -> Buy
2025-09-05BairdInitiate Neutral
2025-08-06JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-08-06NeedhamMaintains Buy -> Buy
2025-08-06BarclaysMaintains Overweight -> Overweight
2025-08-06Evercore ISI GroupMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2026
EPS Estimate
$0.39
Revenue Estimate
175.12M
Revenue Q2Q
41.43%
EPS Q2Q
N/A
Number of Analysts
19

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
8.05%
EPS (1 Month)
0.55%
EPS (3 Months)
28.47%

Next Earnings Summary

The next earnings revenue estimate has been revised upward by 8.05% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2031

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
HNGE revenue by date.HNGE revenue by date.
292.73M390.404M
33.37%		587.86M
50.58%		749.12M
27.43%		888.04M
18.54%		1.054B
18.69%		1.26B
19.54%		1.44B
14.29%		1.625B
12.85%
EBITDA
YoY % growth
HNGE ebitda by date.HNGE ebitda by date.
-124.887M-18.479M
85.20%		-541.238M
-2,828.94%		169.89M
131.39%		211.49M
24.49%		232.98M
10.16%		331.3M
42.20%		382.6M
15.48%		435.64M
13.86%
EBIT
YoY % growth
HNGE ebit by date.HNGE ebit by date.
-130.514M-24.429M
81.28%		-546.371M
-2,136.57%		154M
128.19%		194.08M
26.03%		218.26M
12.46%		315.89M
44.73%		364.96M
15.53%		415.65M
13.89%
Operating Margin
HNGE operating margin by date.HNGE operating margin by date.
-44.59%-6.26%-92.94%20.56%21.85%20.71%25.07%25.34%25.58%
EPS
YoY % growth
HNGE eps by date.HNGE eps by date.
N/AN/AN/A1.93
30.48%		2.31
19.68%		2.83
22.53%		3.45
21.78%		3.87
12.13%		4.28
10.82%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		0.390.44
-37.88%		0.47
6.05%		0.58
17.92%		0.45
15.63%		0.50
14.31%		0.55
18.94%		0.66
14.67%		0.55
22.87%		0.68
34.92%		0.71
28.47%		0.76
14.39%
Revenue
Q2Q % growth		175.12M
41.43%		181.92M
30.79%		190.05M
23.24%		204.28M
19.65%		208.84M
19.26%		214.04M
17.66%		222.84M
17.25%		236.74M
15.89%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		34.096M
136.12%		39.131M
106.77%		41.683M
2,009.44%		53.609M
65.52%		43.157M
26.57%		47.201M
20.62%		51.346M
23.18%		62.439M
16.47%		N/AN/AN/AN/A
EBIT
Q2Q % growth		31.15M
137.12%		36.242M
106.24%		38.772M
736.34%		49.573M
81.88%		39.78M
27.70%		44.107M
21.70%		48.579M
25.29%		59.961M
20.95%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HNGE Yearly Revenue VS EstimatesHNGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B
HNGE Yearly EPS VS EstimatesHNGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 2031 1 2 3 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
24.15%
EPS Next 5 Year
21.18%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
21.67%
Revenue Next 5 Year
19.73%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
29.26%
EBIT Next 5 Year
28.82%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HINGE HEALTH INC-A / HNGE Forecast FAQ

What is the price target for HNGE stock?

23 analysts have analysed HNGE and the average price target is 59.42 USD. This implies a price increase of 56.36% is expected in the next year compared to the current price of 38.

What are the consensus estimates for HINGE HEALTH INC-A (HNGE) next earnings?

The consensus EPS estimate for the next earnings of HINGE HEALTH INC-A (HNGE) is 0.39 USD and the consensus revenue estimate is 175.12M USD.

How many analysts have analysed HINGE HEALTH INC-A (HNGE)?

The number of analysts covering HINGE HEALTH INC-A (HNGE) is 23.